Comment
doi: 10.1016/S0140-6736(12)61888-1.
Epub 2012 Nov 6.
Into the future: diversifying lipid management
Affiliations
- PMID: 23141810
- DOI: 10.1016/S0140-6736(12)61888-1
Item in Clipboard
Comment
Into the future: diversifying lipid management
Lancet.
.
No abstract available
Comment on
-
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study.Lancet. 2012 Dec 8;380(9858):1995-2006. doi: 10.1016/S0140-6736(12)61771-1. Epub 2012 Nov 6. Lancet. 2012. PMID: 23141812 Clinical Trial.
-
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study.Lancet. 2012 Dec 8;380(9858):2007-17. doi: 10.1016/S0140-6736(12)61770-X. Epub 2012 Nov 6. Lancet. 2012. PMID: 23141813 Free PMC article. Clinical Trial.
Similar articles
-
Dyslipidaemia: PCSK9 antibodies: a dividend of the genomics revolution.Nat Rev Cardiol. 2013 Nov;10(11):618-9. doi: 10.1038/nrcardio.2013.139. Epub 2013 Sep 10. Nat Rev Cardiol. 2013. PMID: 24019032 No abstract available.
-
Beyond anti-PCSK9 therapies: the potential role of resistin inhibitors.Nat Rev Cardiol. 2014 Jan;11(1):12. doi: 10.1038/nrcardio.2013.139-c1. Epub 2013 Nov 12. Nat Rev Cardiol. 2014. PMID: 24217159 No abstract available.
-
PCSK9 inhibition: the next statin?J Am Coll Cardiol. 2012 Jun 19;59(25):2354-5. doi: 10.1016/j.jacc.2012.03.011. Epub 2012 Mar 31. J Am Coll Cardiol. 2012. PMID: 22465426 No abstract available.
-
Cardiovascular endocrinology in 2012: PCSK9-an exciting target for reducing LDL-cholesterol levels.Nat Rev Endocrinol. 2013 Feb;9(2):76-8. doi: 10.1038/nrendo.2012.254. Epub 2013 Jan 8. Nat Rev Endocrinol. 2013. PMID: 23296165 Review.
-
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors for Treatment of High Cholesterol Levels: Effectiveness and Value.JAMA Intern Med. 2016 Jan;176(1):107-8. doi: 10.1001/jamainternmed.2015.7248. JAMA Intern Med. 2016. PMID: 26662572 Review. No abstract available.
Cited by
-
The Spectrum of Familial Hypercholesterolemia (FH) in Saudi Arabia: Prime Time for Patient FH Registry.Open Cardiovasc Med J. 2017 Jul 26;11:66-75. doi: 10.2174/1874192401711010066. eCollection 2017. Open Cardiovasc Med J. 2017. PMID: 28868092 Free PMC article. Review.
-
Treatment of dyslipidemia.F1000Prime Rep. 2014 Mar 3;6:17. doi: 10.12703/P6-17. eCollection 2014. F1000Prime Rep. 2014. PMID: 24669298 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
